Skip to main content
Top
Published in: Heart and Vessels 11/2018

Open Access 01-11-2018 | Original Article

Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patients with stable coronary artery disease

Authors: Ilona Korzonek-Szlacheta, Bartosz Hudzik, Justyna Nowak, Janusz Szkodzinski, Jolanta Nowak, Mariusz Gąsior, Barbara Zubelewicz-Szkodzinska

Published in: Heart and Vessels | Issue 11/2018

Login to get access

Abstract

There is little published data on the association of platelet function and 25(OH)D concentration. We investigated the associations between mean platelet volume (MPV) and 25(OH)D concentration in patients with stable coronary artery disease. Study population was divided into three groups: group 1—25(OH)D < 10 ng/mL (N = 22), group 2—25(OH)D 10–20 ng/mL (N = 42), and group 3—25(OH)D > 20 ng/mL (N = 14). Study groups shared similar demographics. MPV values were the highest in group 1, moderate in group 2, and the lowest in group 3 (11.1 vs 10.4 vs 9.8 fL P < 0.001). There was a negative correlation between MPV and 25(OH)D (R = − 0.38, P = 0.001). ROC analysis demonstrated a moderate predictive value (AUC 0.70) in identifying the discrimination thresholds of MPV (> 10.5 fL) for vitamin D deficiency and a weak predictive value (AUC 0.65) in identifying the discrimination thresholds of 25(OH)D concentration (≤ 15.5 ng/mL) for the presence of large platelets (MPV over the upper limit of normal). In conclusion, even though the effect of vitamin D on platelet size and function is probably multifactorial, our study provides further evidence linking vitamin D to thrombosis and hemostasis. Platelets are another potential element through which vitamin D deficiency could exert adverse cardiovascular outcomes.
Literature
1.
go back to reference Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Ni H (2012) Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets 12(2):126–132CrossRef Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Ni H (2012) Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets 12(2):126–132CrossRef
2.
go back to reference Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67(4):499–511CrossRef Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67(4):499–511CrossRef
3.
go back to reference Rondina MT, Weyrich AS, Zimmerman GA (2013) Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 112(11):1506–1519CrossRef Rondina MT, Weyrich AS, Zimmerman GA (2013) Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 112(11):1506–1519CrossRef
4.
go back to reference Li N (2013) CD4+ T cells in atherosclerosis: regulation by platelets. Thromb Haemost 109(6):980–990CrossRef Li N (2013) CD4+ T cells in atherosclerosis: regulation by platelets. Thromb Haemost 109(6):980–990CrossRef
5.
go back to reference Valettas N, Herrmann HC (2003) The role of platelets and platelet inhibition in acute myocardial infarction. Coron Artery Dis 14(5):357–363PubMed Valettas N, Herrmann HC (2003) The role of platelets and platelet inhibition in acute myocardial infarction. Coron Artery Dis 14(5):357–363PubMed
6.
go back to reference Jaumdally RJ, Varma C, Blann AD, MacFadyen RJ, Lip GY (2007) Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. Chest 132(5):1532–1539CrossRef Jaumdally RJ, Varma C, Blann AD, MacFadyen RJ, Lip GY (2007) Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. Chest 132(5):1532–1539CrossRef
7.
go back to reference Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50(3):509–519CrossRef Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50(3):509–519CrossRef
8.
go back to reference Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63(10):1509–1515CrossRef Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63(10):1509–1515CrossRef
9.
go back to reference Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8(1):148–156CrossRef Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8(1):148–156CrossRef
10.
go back to reference Choi DH, Kang SH, Song H (2016) Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease. Korean J Intern Med 31(6):1009–1017CrossRef Choi DH, Kang SH, Song H (2016) Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease. Korean J Intern Med 31(6):1009–1017CrossRef
11.
go back to reference Noris P, Melazzini F, Balduini CL (2016) New roles for mean platelet volume measurement in the clinical practice? Platelets 27(7):607–612CrossRef Noris P, Melazzini F, Balduini CL (2016) New roles for mean platelet volume measurement in the clinical practice? Platelets 27(7):607–612CrossRef
12.
go back to reference Sansanayudh N, Numthavaj P, Muntham D, Yamwong S, McEvoy M, Attia J, Sritara P, Thakkinstian A (2015) Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost 114(6):1299–1309CrossRef Sansanayudh N, Numthavaj P, Muntham D, Yamwong S, McEvoy M, Attia J, Sritara P, Thakkinstian A (2015) Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost 114(6):1299–1309CrossRef
13.
go back to reference Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57–S73PubMed Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57–S73PubMed
14.
go back to reference de Borst MH, de Boer RA, Stolk RP, Slaets JP, Wolffenbuttel BH, Navis G (2011) Vitamin D deficiency: universal risk factor for multifactorial diseases? Curr Drug Targets 12(1):97–106CrossRef de Borst MH, de Boer RA, Stolk RP, Slaets JP, Wolffenbuttel BH, Navis G (2011) Vitamin D deficiency: universal risk factor for multifactorial diseases? Curr Drug Targets 12(1):97–106CrossRef
15.
go back to reference Pike JW, Christakos S (2017) Biology and mechanisms of action of the Vitamin D hormone. Endocrinol Metab Clin N Am 46(4):815–843CrossRef Pike JW, Christakos S (2017) Biology and mechanisms of action of the Vitamin D hormone. Endocrinol Metab Clin N Am 46(4):815–843CrossRef
16.
go back to reference Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165CrossRef Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165CrossRef
17.
go back to reference Targher G, Pichiri I, Lippi G (2012) Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost 38(1):114–124CrossRef Targher G, Pichiri I, Lippi G (2012) Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost 38(1):114–124CrossRef
18.
go back to reference Jorde R, Haug E, Figenschau Y, Hansen JB (2007) Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromso study. Acta Haematol 117(2):91–97CrossRef Jorde R, Haug E, Figenschau Y, Hansen JB (2007) Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromso study. Acta Haematol 117(2):91–97CrossRef
19.
go back to reference Hypponen E, Berry D, Cortina-Borja M, Power C (2010) 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 5(5):e10801CrossRef Hypponen E, Berry D, Cortina-Borja M, Power C (2010) 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 5(5):e10801CrossRef
20.
go back to reference Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R (2000) 1alpha, 25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 102(23):2867–2872CrossRef Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R (2000) 1alpha, 25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 102(23):2867–2872CrossRef
21.
go back to reference Chen Y, Kong J, Sun T, Li G, Szeto FL, Liu W, Deb DK, Wang Y, Zhao Q, Thadhani R, Li YC (2011) 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation. Arch Biochem Biophys 507(2):241–247CrossRef Chen Y, Kong J, Sun T, Li G, Szeto FL, Liu W, Deb DK, Wang Y, Zhao Q, Thadhani R, Li YC (2011) 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation. Arch Biochem Biophys 507(2):241–247CrossRef
22.
go back to reference Cumhur Cure M, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H (2014) Mean platelet volume and vitamin D level. Ann Lab Med 34(2):98–103CrossRef Cumhur Cure M, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H (2014) Mean platelet volume and vitamin D level. Ann Lab Med 34(2):98–103CrossRef
23.
go back to reference Kebapcilar AG, Kulaksizoglu M, Ipekci SH, Korkmaz H, Kebapcilar L, Akyurek F, Taner CE, Gonen MS (2013) Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency. Arch Gynecol Obstet 288(1):207–212CrossRef Kebapcilar AG, Kulaksizoglu M, Ipekci SH, Korkmaz H, Kebapcilar L, Akyurek F, Taner CE, Gonen MS (2013) Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency. Arch Gynecol Obstet 288(1):207–212CrossRef
24.
go back to reference Verdoia M, Pergolini P, Rolla R, Sartori C, Nardin M, Schaffer A, Barbieri L, Daffara V, Marino P, Bellomo G, Suryapranata H, Luca GD (2016) Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Platelets 27(6):576–582CrossRef Verdoia M, Pergolini P, Rolla R, Sartori C, Nardin M, Schaffer A, Barbieri L, Daffara V, Marino P, Bellomo G, Suryapranata H, Luca GD (2016) Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Platelets 27(6):576–582CrossRef
25.
go back to reference Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, Pescarmona G (2010) Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One 5(1):e8670CrossRef Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, Pescarmona G (2010) Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One 5(1):e8670CrossRef
26.
go back to reference Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T, Hayashi H, Yamada Y, Endoh F, Fujimura M, Yoshida T, Yamaguchi H, Hashizume S, Kato M, Yoshimura K, Yamamoto Y, Kato S, Matsumoto T (2004) Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279(34):35798–35802CrossRef Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T, Hayashi H, Yamada Y, Endoh F, Fujimura M, Yoshida T, Yamaguchi H, Hashizume S, Kato M, Yoshimura K, Yamamoto Y, Kato S, Matsumoto T (2004) Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279(34):35798–35802CrossRef
27.
go back to reference Aihara K, Azuma H, Matsumoto T (2006) Vitamin D–vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium 16(7):1173–1179PubMed Aihara K, Azuma H, Matsumoto T (2006) Vitamin D–vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium 16(7):1173–1179PubMed
29.
go back to reference Meems LM, de Borst MH, Postma DS, Vonk JM, Kremer HP, Schuttelaar ML, Rosmalen JG, Weersma RK, Wolffenbuttel BH, Scholtens S, Stolk RP, Kema IP, Navis G, Khan MA, van der Harst P, de Boer RA (2015) Low levels of vitamin D are associated with multimorbidity: results from the LifeLines Cohort Study. Ann Med 47(6):474–481CrossRef Meems LM, de Borst MH, Postma DS, Vonk JM, Kremer HP, Schuttelaar ML, Rosmalen JG, Weersma RK, Wolffenbuttel BH, Scholtens S, Stolk RP, Kema IP, Navis G, Khan MA, van der Harst P, de Boer RA (2015) Low levels of vitamin D are associated with multimorbidity: results from the LifeLines Cohort Study. Ann Med 47(6):474–481CrossRef
30.
go back to reference Silvain J, Cayla G, Hulot JS, Finzi J, Kerneis M, O’Connor SA, Bellemain-Appaix A, Barthelemy O, Beygui F, Collet JP, Montalescot G (2012) High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study. Eur Heart J 33(10):1241–1249CrossRef Silvain J, Cayla G, Hulot JS, Finzi J, Kerneis M, O’Connor SA, Bellemain-Appaix A, Barthelemy O, Beygui F, Collet JP, Montalescot G (2012) High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study. Eur Heart J 33(10):1241–1249CrossRef
31.
go back to reference Verouti SN, Tsoupras AB, Alevizopoulou F, Demopoulos CA, Iatrou C (2013) Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. Int J Artif Organs 36(2):87–96CrossRef Verouti SN, Tsoupras AB, Alevizopoulou F, Demopoulos CA, Iatrou C (2013) Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. Int J Artif Organs 36(2):87–96CrossRef
32.
go back to reference Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–329CrossRef Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–329CrossRef
33.
go back to reference Mostafa WZ, Hegazy RA (2015) Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res 6(6):793–804CrossRef Mostafa WZ, Hegazy RA (2015) Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res 6(6):793–804CrossRef
Metadata
Title
Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patients with stable coronary artery disease
Authors
Ilona Korzonek-Szlacheta
Bartosz Hudzik
Justyna Nowak
Janusz Szkodzinski
Jolanta Nowak
Mariusz Gąsior
Barbara Zubelewicz-Szkodzinska
Publication date
01-11-2018
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 11/2018
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1182-9

Other articles of this Issue 11/2018

Heart and Vessels 11/2018 Go to the issue